Oberhaching, April 2022
To whom it may concern
We hereby wish to inform you about a change in personnel at Bendalis GmbH and Lyomark Pharma GmbH.
Mr Parvany will leave the company on 31 March 2022. Mr Parvany has been involved in both companies since 2012, joining as head of sales and marketing and becoming managing director in 2017.
We wish to take this opportunity to thank Mr Parvany for his tremendous commitment over the years, which has been pivotal to the success of the business. We wish him all the best for the future.
As of 1 April 2022, Dr Dirk Hütten will join the management team alongside Dr Burger. Dr Hütten has more than 20 years of pharmaceutical supply chain experience, having held various positions in international sales.
We are delighted to welcome Dr Dirk Hütten as managing director and wish him every success.
The partners of Lyomark Pharma GmbH and Bendalis GmbH